Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Nektar Therapeutics changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 197 | 148 | −49 |
| Shares | 172.7M | 137.9M | −34.8M (−20.2%) |
| Value | $121.2M | $79.3M | −$41.8M (−34.5%) |
New holders (25)
Institutions that held Nektar Therapeutics at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (74)
Institutions that held Nektar Therapeutics at the end of Q1 2023 and filed for Q2 2023 without it.